Role of mitochondria in progression of cancer: a semi-quantitative study

Deepali Jain, Pooja Lohiya, Minal Chaudhary, Madhuri Gawande, Swati Patil, Sourabh Kumar Jain

Abstract


Mitochondria have been an area of scientific study for more than 100 years. It was in early 20th century that Otto Warburg first described differences in the mitochondria of tumors v/s normal cells. It was observed that tumor cells have increased rate of aerobic glycolysis compared with normal cells. The study was carried out in patients diagnosed as premalignant and malignant conditions which had three objectives that is to demonstrate the presence or absence of mitochondria in cytological smears, in order to perform a semi-quantitative analysis on the number of mitochondria and to identify the difference in distribution mitochondria if any. The study was carried out in the Department of Oral and Maxillofacial Pathology of S.P.D.C., Sawangi, Wardha with consent from patients and approval from the institutional ethical committee. 20 patients each diagnosed clinically and histo-pathologically with OSCC and Premalignant conditions or lesions respectively were selected for the purpose of the study. 20 subjects who had come for routine endodontic treatment were taken as control group for the purpose of the study. It was observed that there was even distribution of mitochondria throughout the cytoplasm in smear that had been taken from normal mucosa which appeared sharply defined whereas in premalignant mitochondria were located in the perinuclear zone and 10% in the peripheral zone and in malignant conditions distribution was sparse in the perinuclear area and appeared ill-defined.


Keywords


Mitochondria, Premalignant, Malignant, Warburg Effect, Altmann stain, Cancer

Full Text:

PDF

References


Alirol1 E, Martinou JC. Mitochondria and cancer: is there a morphological connection? Depaartment of Cell Biology, University of Geneva, Gene`ve, Switzerland. Oncogene (2006) 25, 4706–4716.

Expression of mitochondrial ncRNAs is modulated by high risk HPV oncogenes. Claudio Villota.

Mitochondria in cancer G Kroemer11CNRS-FRE2939, Institut Gustave Roussy, Villejuif, France. Oncogene (2006) 25, 4630–4632.

Morphological and functional changes of mitochondria in apoptotic esophageal carcinoma cells induced by arsenic trioxide World J Gastroenterol.2002 Feb;8(1):315.4.

Mitochondrial impairment in p53-deficient human cancer cells. Oxford Journals Life Sciences &Medicine&MutagenesisVolume18, Issue3Pp. 287-292.

Josephine S. Modica Napolitano and Keshav Singh, Mitochondria as targets for detection and treatment of cancer, Molecular Medicine/Vol.4/Issue 09 / April 2002, pp 119.

J. Bereiter-Hahn and M. Voth,Dynamics of Mitochondria in Living Cells: SChanges, Dislocations, Fusion, and Fission of Mitochondria, Cinematic Cell Research Group, Johann Wolfgang Goethe Universitat, 0 6000 Frankfurt am Main, Germany (J.B.-H.,M.V.).

Vladimir Gogvadze, Sten Orrenius and Boris Zhivotovsky Mitochondria in cancer cells: what is so special about them? Institute of Environmental Medicine, Division of Toxicology, Karolinska Institutet, Box 210,Stockholm, SE-171 77, Sweden Trends in Cell Biology Vol.18 No.4.

Techniques of histological staining by Bancroft. Sixth edition.

Kroemer. Mitochondria in cancer Oncogene (2006) 25, 4630–4632. doi:10.1038/sj.onc.120.

Shen ZY, Shen J, Li QS, Chen CY, Chen JY, Yi Z. Morphological and functional changes of mitochondria in apoptotic esophageal carcinoma cells induced by arsenic trioxide World J Gastroenterol.2002 Feb;8(1):31-5.

Shaoyu Zhou, Sushant Kachhap and Keshav K. Singh. Mitochondrial impairment in p53-deficient human cancer cells. Oxford Journals Life Sciences&Medicine&MutagenesisVolume18, Issue 3Pp. 287-292.

Association of human papilloma virus with oral squamous cell carcinoma-a brief review; journal of oral and maxillofacial pathology;vol.no.2 july-dec 2010issn0976-1225.